STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
慢性淋巴细胞白血病中的 STAT 信号转导
基本信息
- 批准号:6626615
- 负责人:
- 金额:$ 27.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-07 至 2004-12-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte DNA binding protein SDS polyacrylamide gel electrophoresis biological signal transduction cell growth regulation chronic lymphocytic leukemia clinical research cytogenetics cytokine drug adverse effect flow cytometry fludarabine gel mobility shift assay gene expression gene induction /repression human subject immunocytochemistry immunoprecipitation leukocyte activation /transformation molecular cloning neoplastic growth phosphorylation protein tyrosine kinase tissue /cell culture transcription factor western blottings
项目摘要
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia
in the United States. However, an understanding of the molecular
abnormalities which underlie this disease is lacking. CLL is
characterized by the continuous unrestrained growth of B lymphocytes.
As such, a defect in a signaling pathway that controls the regulation
of mitosis in B lymphocytes might be responsible for this malignancy.
The proliferation of B lymphocytes is normally closely regulated by a
family of secreted cytokines which act by binding to specific cell
surface receptors. Upon binding to their cognate receptor, most
cytokines signal, at least in part, by activating a set of transcription
factors known as STATs. STATs can be phosphorylated on a single
tyrosine residue, which leads to STAT dimerization, nuclear
translocation, DNA binding, and transcriptional activation. In
addition, the function of several STATs is modulated by phosphorylation
on specific serine residues. This additional serine phosphorylation
appears to be important for gene activation, and may serve to integrate
signals generated by diverse intracellular pathways. Given the central
role of STATs in modulating the growth and function of B lymphocytes,
we considered the possibility that abnormalities in STAT-mediated
signaling might underlie the defective growth regulation seen in the
malignant B lymphocytes of CLL. We have recently reported that although
tyrosine phosphorylation of STATs is not present in CLL, constitutive
phosphorylation of STAT1 and STAT3 on specific serine residues, ser-727
in each protein, is found in the peripheral blood B lymphocytes of all
patients with CLL examined thus far, but not in normal B cells. The
present proposal seeks to extend these findings by exploring the
mechanism of this phosphorylation and its consequence in the biology of
CLL. Four specific aims will be pursued: (1) To analyze the effect that
serine phosphorylation of STAT1 and STAT3 plays in mediating gene
activation and cell survival in CLL cells and normal lymphocytes; (2)
To determine the effect that inhibition of STAT tyrosine phosphorylation
has on the biology of transformed B lymphocytes; (3) To analyze the
effect that a chemotherapeutic drug used to treat CLL, fludarabine, has
on STAT signaling; and (4) To isolate the kinase(s) responsible for the
phosphorylation of ser-727 of STAT1 and STAT3 in CLL cells. As a result
of these experiments, we plan to discern the role of STATs in the
abnormal growth of CLL cells, and to identify targets for novel and
specific therapies.
慢性淋巴细胞白血病(CLL)是最常见的白血病
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways.
- DOI:10.1182/blood.v96.10.3422.h8003422_3422_3430
- 发表时间:2000-11
- 期刊:
- 影响因子:20.3
- 作者:Rafael F Duarte;D. Frank
- 通讯作者:Rafael F Duarte;D. Frank
In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.
慢性淋巴细胞白血病 CD154 基因治疗后信号转导器和转录激活剂 1 的体内激活与临床和免疫反应相关。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Battle,TraciE;Wierda,WilliamG;Rassenti,LauraZ;Zahrieh,David;Neuberg,Donna;Kipps,ThomasJ;Frank,DavidA
- 通讯作者:Frank,DavidA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A. FRANK其他文献
DAVID A. FRANK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A. FRANK', 18)}}的其他基金
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy
用于癌症靶向治疗的 STAT3/NF-kB 双抑制剂
- 批准号:
9037605 - 财政年份:2012
- 资助金额:
$ 27.23万 - 项目类别:
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy
用于癌症靶向治疗的 STAT3/NF-kB 双抑制剂
- 批准号:
8641668 - 财政年份:2012
- 资助金额:
$ 27.23万 - 项目类别:
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy
用于癌症靶向治疗的 STAT3/NF-kB 双抑制剂
- 批准号:
8295417 - 财政年份:2012
- 资助金额:
$ 27.23万 - 项目类别:
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy
用于癌症靶向治疗的 STAT3/NF-kB 双抑制剂
- 批准号:
8463484 - 财政年份:2012
- 资助金额:
$ 27.23万 - 项目类别:
STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer
STAT3在胰腺癌发病机制和治疗中的作用
- 批准号:
7132182 - 财政年份:2006
- 资助金额:
$ 27.23万 - 项目类别:
STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer
STAT3在胰腺癌发病机制和治疗中的作用
- 批准号:
7268155 - 财政年份:2006
- 资助金额:
$ 27.23万 - 项目类别:
High Throughput Screening for Modulators of STAT5 (RMI)
STAT5 调制器的高通量筛选 (RMI)
- 批准号:
6879437 - 财政年份:2004
- 资助金额:
$ 27.23万 - 项目类别:
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
慢性淋巴细胞白血病中的 STAT 信号转导
- 批准号:
2726415 - 财政年份:1999
- 资助金额:
$ 27.23万 - 项目类别:
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
慢性淋巴细胞白血病中的 STAT 信号转导
- 批准号:
6342108 - 财政年份:1999
- 资助金额:
$ 27.23万 - 项目类别:
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
慢性淋巴细胞白血病中的 STAT 信号转导
- 批准号:
6137684 - 财政年份:1999
- 资助金额:
$ 27.23万 - 项目类别:
相似海外基金
Targeting pathogenic TAR DNA-binding protein 43 to treat frontotemporal dementia and motor neuron disease
靶向致病性 TAR DNA 结合蛋白 43 治疗额颞叶痴呆和运动神经元疾病
- 批准号:
nhmrc : 2001572 - 财政年份:2021
- 资助金额:
$ 27.23万 - 项目类别:
Ideas Grants
Electron microscopic analysis of a G4 DNA-binding protein Rif1, a key organizer of chromosomal domains
G4 DNA 结合蛋白 Rif1(染色体结构域的关键组织者)的电子显微镜分析
- 批准号:
18K06102 - 财政年份:2018
- 资助金额:
$ 27.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of methylated DNA-binding protein CIBZ in mouse embryogenesis
甲基化DNA结合蛋白CIBZ在小鼠胚胎发生中的功能分析
- 批准号:
16K08587 - 财政年份:2016
- 资助金额:
$ 27.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
- 批准号:
437922-2013 - 财政年份:2015
- 资助金额:
$ 27.23万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
- 批准号:
459937-2014 - 财政年份:2015
- 资助金额:
$ 27.23万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Function and evolution of mitochondrial DNA-binding protein in the fission yeast
裂殖酵母线粒体DNA结合蛋白的功能和进化
- 批准号:
15K07168 - 财政年份:2015
- 资助金额:
$ 27.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of the single-stranded DNA-binding protein FUBP1 as a transcriptional regulator of hematopoietic stem cell self-renewal
单链DNA结合蛋白FUBP1作为造血干细胞自我更新转录调节因子的功能分析
- 批准号:
276833671 - 财政年份:2015
- 资助金额:
$ 27.23万 - 项目类别:
Research Grants
Continuous directed evolution of a light-controlled DNA-binding protein
光控DNA结合蛋白的连续定向进化
- 批准号:
437922-2013 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Postgraduate Scholarships - Doctoral
Structural ans functional analysis of single-stranded DNA-binding protein DdrA
单链 DNA 结合蛋白 DdrA 的结构和功能分析
- 批准号:
26506030 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a photo-controlled DNA-binding protein
光控 DNA 结合蛋白的开发
- 批准号:
459937-2014 - 财政年份:2014
- 资助金额:
$ 27.23万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral